Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow IMAC Holdings, Inc.

Get SEC filing alerts via email and in your feed for IMAC Holdings, Inc.

BACK IMACW

IMAC Holdings, Inc.

About IMAC Holdings, Inc.

IMAC Holdings, Inc. develops proteomic diagnostic products for oncology, supporting personalized cancer treatment and biopharmaceutical research. Its core technology, RPPA, analyzes protein signaling to guide therapy decisions, primarily in breast cancer. The company licenses intellectual property from universities, operates a clinical lab, and targets healthcare providers, aiming to expand its biomarker portfolio and market presence in the U.S. cancer diagnostics sector.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from IMAC Holdings, Inc.

1
1
2
1
3
1
4
1
5
1
6
1